Global Trastuzumab Biosimilars Supply, Demand and Key Producers, 2023-2029
The global Trastuzumab Biosimilars market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
Trastuzumab is used for the treatment of HER2-positive early breast cancer, metastatic breast cancer and metastatic gastric cancer.
This report studies the global Trastuzumab Biosimilars production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Trastuzumab Biosimilars, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Trastuzumab Biosimilars that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Trastuzumab Biosimilars total production and demand, 2018-2029, (K Units)
Global Trastuzumab Biosimilars total production value, 2018-2029, (USD Million)
Global Trastuzumab Biosimilars production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Trastuzumab Biosimilars consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Trastuzumab Biosimilars domestic production, consumption, key domestic manufacturers and share
Global Trastuzumab Biosimilars production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Trastuzumab Biosimilars production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Trastuzumab Biosimilars production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units).
This reports profiles key players in the global Trastuzumab Biosimilars market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Fosun International Limited, Anhui Anke Bioengineering, Hisun Biopharmaceuticals, Chia Tai Tianqing Pharmaceutical Group, Genentech Inc, Daiichi Sankyo, Pfizer, Celltrion Healthcare and Baxter Oncology GmbH, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Trastuzumab Biosimilars market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Trastuzumab Biosimilars Market, By Region:
1. How big is the global Trastuzumab Biosimilars market?
2. What is the demand of the global Trastuzumab Biosimilars market?
3. What is the year over year growth of the global Trastuzumab Biosimilars market?
4. What is the production and production value of the global Trastuzumab Biosimilars market?
5. Who are the key producers in the global Trastuzumab Biosimilars market?
Trastuzumab is used for the treatment of HER2-positive early breast cancer, metastatic breast cancer and metastatic gastric cancer.
This report studies the global Trastuzumab Biosimilars production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Trastuzumab Biosimilars, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Trastuzumab Biosimilars that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Trastuzumab Biosimilars total production and demand, 2018-2029, (K Units)
Global Trastuzumab Biosimilars total production value, 2018-2029, (USD Million)
Global Trastuzumab Biosimilars production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Trastuzumab Biosimilars consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Trastuzumab Biosimilars domestic production, consumption, key domestic manufacturers and share
Global Trastuzumab Biosimilars production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Trastuzumab Biosimilars production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Trastuzumab Biosimilars production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units).
This reports profiles key players in the global Trastuzumab Biosimilars market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Fosun International Limited, Anhui Anke Bioengineering, Hisun Biopharmaceuticals, Chia Tai Tianqing Pharmaceutical Group, Genentech Inc, Daiichi Sankyo, Pfizer, Celltrion Healthcare and Baxter Oncology GmbH, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Trastuzumab Biosimilars market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Trastuzumab Biosimilars Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Humanized Trastuzumab
- Animal-derived Trastuzumab
- Hospital
- Clinic
- Fosun International Limited
- Anhui Anke Bioengineering
- Hisun Biopharmaceuticals
- Chia Tai Tianqing Pharmaceutical Group
- Genentech Inc
- Daiichi Sankyo
- Pfizer
- Celltrion Healthcare
- Baxter Oncology GmbH
- Sandoz
1. How big is the global Trastuzumab Biosimilars market?
2. What is the demand of the global Trastuzumab Biosimilars market?
3. What is the year over year growth of the global Trastuzumab Biosimilars market?
4. What is the production and production value of the global Trastuzumab Biosimilars market?
5. Who are the key producers in the global Trastuzumab Biosimilars market?
1 SUPPLY SUMMARY
1.1 Trastuzumab Biosimilars Introduction
1.2 World Trastuzumab Biosimilars Supply & Forecast
1.2.1 World Trastuzumab Biosimilars Production Value (2018 & 2022 & 2029)
1.2.2 World Trastuzumab Biosimilars Production (2018-2029)
1.2.3 World Trastuzumab Biosimilars Pricing Trends (2018-2029)
1.3 World Trastuzumab Biosimilars Production by Region (Based on Production Site)
1.3.1 World Trastuzumab Biosimilars Production Value by Region (2018-2029)
1.3.2 World Trastuzumab Biosimilars Production by Region (2018-2029)
1.3.3 World Trastuzumab Biosimilars Average Price by Region (2018-2029)
1.3.4 North America Trastuzumab Biosimilars Production (2018-2029)
1.3.5 Europe Trastuzumab Biosimilars Production (2018-2029)
1.3.6 China Trastuzumab Biosimilars Production (2018-2029)
1.3.7 Japan Trastuzumab Biosimilars Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Trastuzumab Biosimilars Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Trastuzumab Biosimilars Major Market Trends
2 DEMAND SUMMARY
2.1 World Trastuzumab Biosimilars Demand (2018-2029)
2.2 World Trastuzumab Biosimilars Consumption by Region
2.2.1 World Trastuzumab Biosimilars Consumption by Region (2018-2023)
2.2.2 World Trastuzumab Biosimilars Consumption Forecast by Region (2024-2029)
2.3 United States Trastuzumab Biosimilars Consumption (2018-2029)
2.4 China Trastuzumab Biosimilars Consumption (2018-2029)
2.5 Europe Trastuzumab Biosimilars Consumption (2018-2029)
2.6 Japan Trastuzumab Biosimilars Consumption (2018-2029)
2.7 South Korea Trastuzumab Biosimilars Consumption (2018-2029)
2.8 ASEAN Trastuzumab Biosimilars Consumption (2018-2029)
2.9 India Trastuzumab Biosimilars Consumption (2018-2029)
3 WORLD TRASTUZUMAB BIOSIMILARS MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Trastuzumab Biosimilars Production Value by Manufacturer (2018-2023)
3.2 World Trastuzumab Biosimilars Production by Manufacturer (2018-2023)
3.3 World Trastuzumab Biosimilars Average Price by Manufacturer (2018-2023)
3.4 Trastuzumab Biosimilars Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Trastuzumab Biosimilars Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Trastuzumab Biosimilars in 2022
3.5.3 Global Concentration Ratios (CR8) for Trastuzumab Biosimilars in 2022
3.6 Trastuzumab Biosimilars Market: Overall Company Footprint Analysis
3.6.1 Trastuzumab Biosimilars Market: Region Footprint
3.6.2 Trastuzumab Biosimilars Market: Company Product Type Footprint
3.6.3 Trastuzumab Biosimilars Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Trastuzumab Biosimilars Production Value Comparison
4.1.1 United States VS China: Trastuzumab Biosimilars Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Trastuzumab Biosimilars Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Trastuzumab Biosimilars Production Comparison
4.2.1 United States VS China: Trastuzumab Biosimilars Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Trastuzumab Biosimilars Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Trastuzumab Biosimilars Consumption Comparison
4.3.1 United States VS China: Trastuzumab Biosimilars Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Trastuzumab Biosimilars Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Trastuzumab Biosimilars Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Trastuzumab Biosimilars Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Trastuzumab Biosimilars Production Value (2018-2023)
4.4.3 United States Based Manufacturers Trastuzumab Biosimilars Production (2018-2023)
4.5 China Based Trastuzumab Biosimilars Manufacturers and Market Share
4.5.1 China Based Trastuzumab Biosimilars Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Trastuzumab Biosimilars Production Value (2018-2023)
4.5.3 China Based Manufacturers Trastuzumab Biosimilars Production (2018-2023)
4.6 Rest of World Based Trastuzumab Biosimilars Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Trastuzumab Biosimilars Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Trastuzumab Biosimilars Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Trastuzumab Biosimilars Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Trastuzumab Biosimilars Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Humanized Trastuzumab
5.2.2 Animal-derived Trastuzumab
5.3 Market Segment by Type
5.3.1 World Trastuzumab Biosimilars Production by Type (2018-2029)
5.3.2 World Trastuzumab Biosimilars Production Value by Type (2018-2029)
5.3.3 World Trastuzumab Biosimilars Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Trastuzumab Biosimilars Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Hospital
6.2.2 Clinic
6.3 Market Segment by Application
6.3.1 World Trastuzumab Biosimilars Production by Application (2018-2029)
6.3.2 World Trastuzumab Biosimilars Production Value by Application (2018-2029)
6.3.3 World Trastuzumab Biosimilars Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 Fosun International Limited
7.1.1 Fosun International Limited Details
7.1.2 Fosun International Limited Major Business
7.1.3 Fosun International Limited Trastuzumab Biosimilars Product and Services
7.1.4 Fosun International Limited Trastuzumab Biosimilars Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Fosun International Limited Recent Developments/Updates
7.1.6 Fosun International Limited Competitive Strengths & Weaknesses
7.2 Anhui Anke Bioengineering
7.2.1 Anhui Anke Bioengineering Details
7.2.2 Anhui Anke Bioengineering Major Business
7.2.3 Anhui Anke Bioengineering Trastuzumab Biosimilars Product and Services
7.2.4 Anhui Anke Bioengineering Trastuzumab Biosimilars Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Anhui Anke Bioengineering Recent Developments/Updates
7.2.6 Anhui Anke Bioengineering Competitive Strengths & Weaknesses
7.3 Hisun Biopharmaceuticals
7.3.1 Hisun Biopharmaceuticals Details
7.3.2 Hisun Biopharmaceuticals Major Business
7.3.3 Hisun Biopharmaceuticals Trastuzumab Biosimilars Product and Services
7.3.4 Hisun Biopharmaceuticals Trastuzumab Biosimilars Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Hisun Biopharmaceuticals Recent Developments/Updates
7.3.6 Hisun Biopharmaceuticals Competitive Strengths & Weaknesses
7.4 Chia Tai Tianqing Pharmaceutical Group
7.4.1 Chia Tai Tianqing Pharmaceutical Group Details
7.4.2 Chia Tai Tianqing Pharmaceutical Group Major Business
7.4.3 Chia Tai Tianqing Pharmaceutical Group Trastuzumab Biosimilars Product and Services
7.4.4 Chia Tai Tianqing Pharmaceutical Group Trastuzumab Biosimilars Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Chia Tai Tianqing Pharmaceutical Group Recent Developments/Updates
7.4.6 Chia Tai Tianqing Pharmaceutical Group Competitive Strengths & Weaknesses
7.5 Genentech Inc
7.5.1 Genentech Inc Details
7.5.2 Genentech Inc Major Business
7.5.3 Genentech Inc Trastuzumab Biosimilars Product and Services
7.5.4 Genentech Inc Trastuzumab Biosimilars Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Genentech Inc Recent Developments/Updates
7.5.6 Genentech Inc Competitive Strengths & Weaknesses
7.6 Daiichi Sankyo
7.6.1 Daiichi Sankyo Details
7.6.2 Daiichi Sankyo Major Business
7.6.3 Daiichi Sankyo Trastuzumab Biosimilars Product and Services
7.6.4 Daiichi Sankyo Trastuzumab Biosimilars Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Daiichi Sankyo Recent Developments/Updates
7.6.6 Daiichi Sankyo Competitive Strengths & Weaknesses
7.7 Pfizer
7.7.1 Pfizer Details
7.7.2 Pfizer Major Business
7.7.3 Pfizer Trastuzumab Biosimilars Product and Services
7.7.4 Pfizer Trastuzumab Biosimilars Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Pfizer Recent Developments/Updates
7.7.6 Pfizer Competitive Strengths & Weaknesses
7.8 Celltrion Healthcare
7.8.1 Celltrion Healthcare Details
7.8.2 Celltrion Healthcare Major Business
7.8.3 Celltrion Healthcare Trastuzumab Biosimilars Product and Services
7.8.4 Celltrion Healthcare Trastuzumab Biosimilars Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 Celltrion Healthcare Recent Developments/Updates
7.8.6 Celltrion Healthcare Competitive Strengths & Weaknesses
7.9 Baxter Oncology GmbH
7.9.1 Baxter Oncology GmbH Details
7.9.2 Baxter Oncology GmbH Major Business
7.9.3 Baxter Oncology GmbH Trastuzumab Biosimilars Product and Services
7.9.4 Baxter Oncology GmbH Trastuzumab Biosimilars Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 Baxter Oncology GmbH Recent Developments/Updates
7.9.6 Baxter Oncology GmbH Competitive Strengths & Weaknesses
7.10 Sandoz
7.10.1 Sandoz Details
7.10.2 Sandoz Major Business
7.10.3 Sandoz Trastuzumab Biosimilars Product and Services
7.10.4 Sandoz Trastuzumab Biosimilars Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 Sandoz Recent Developments/Updates
7.10.6 Sandoz Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Trastuzumab Biosimilars Industry Chain
8.2 Trastuzumab Biosimilars Upstream Analysis
8.2.1 Trastuzumab Biosimilars Core Raw Materials
8.2.2 Main Manufacturers of Trastuzumab Biosimilars Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Trastuzumab Biosimilars Production Mode
8.6 Trastuzumab Biosimilars Procurement Model
8.7 Trastuzumab Biosimilars Industry Sales Model and Sales Channels
8.7.1 Trastuzumab Biosimilars Sales Model
8.7.2 Trastuzumab Biosimilars Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Trastuzumab Biosimilars Introduction
1.2 World Trastuzumab Biosimilars Supply & Forecast
1.2.1 World Trastuzumab Biosimilars Production Value (2018 & 2022 & 2029)
1.2.2 World Trastuzumab Biosimilars Production (2018-2029)
1.2.3 World Trastuzumab Biosimilars Pricing Trends (2018-2029)
1.3 World Trastuzumab Biosimilars Production by Region (Based on Production Site)
1.3.1 World Trastuzumab Biosimilars Production Value by Region (2018-2029)
1.3.2 World Trastuzumab Biosimilars Production by Region (2018-2029)
1.3.3 World Trastuzumab Biosimilars Average Price by Region (2018-2029)
1.3.4 North America Trastuzumab Biosimilars Production (2018-2029)
1.3.5 Europe Trastuzumab Biosimilars Production (2018-2029)
1.3.6 China Trastuzumab Biosimilars Production (2018-2029)
1.3.7 Japan Trastuzumab Biosimilars Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Trastuzumab Biosimilars Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Trastuzumab Biosimilars Major Market Trends
2 DEMAND SUMMARY
2.1 World Trastuzumab Biosimilars Demand (2018-2029)
2.2 World Trastuzumab Biosimilars Consumption by Region
2.2.1 World Trastuzumab Biosimilars Consumption by Region (2018-2023)
2.2.2 World Trastuzumab Biosimilars Consumption Forecast by Region (2024-2029)
2.3 United States Trastuzumab Biosimilars Consumption (2018-2029)
2.4 China Trastuzumab Biosimilars Consumption (2018-2029)
2.5 Europe Trastuzumab Biosimilars Consumption (2018-2029)
2.6 Japan Trastuzumab Biosimilars Consumption (2018-2029)
2.7 South Korea Trastuzumab Biosimilars Consumption (2018-2029)
2.8 ASEAN Trastuzumab Biosimilars Consumption (2018-2029)
2.9 India Trastuzumab Biosimilars Consumption (2018-2029)
3 WORLD TRASTUZUMAB BIOSIMILARS MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Trastuzumab Biosimilars Production Value by Manufacturer (2018-2023)
3.2 World Trastuzumab Biosimilars Production by Manufacturer (2018-2023)
3.3 World Trastuzumab Biosimilars Average Price by Manufacturer (2018-2023)
3.4 Trastuzumab Biosimilars Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Trastuzumab Biosimilars Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Trastuzumab Biosimilars in 2022
3.5.3 Global Concentration Ratios (CR8) for Trastuzumab Biosimilars in 2022
3.6 Trastuzumab Biosimilars Market: Overall Company Footprint Analysis
3.6.1 Trastuzumab Biosimilars Market: Region Footprint
3.6.2 Trastuzumab Biosimilars Market: Company Product Type Footprint
3.6.3 Trastuzumab Biosimilars Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Trastuzumab Biosimilars Production Value Comparison
4.1.1 United States VS China: Trastuzumab Biosimilars Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Trastuzumab Biosimilars Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Trastuzumab Biosimilars Production Comparison
4.2.1 United States VS China: Trastuzumab Biosimilars Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Trastuzumab Biosimilars Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Trastuzumab Biosimilars Consumption Comparison
4.3.1 United States VS China: Trastuzumab Biosimilars Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Trastuzumab Biosimilars Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Trastuzumab Biosimilars Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Trastuzumab Biosimilars Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Trastuzumab Biosimilars Production Value (2018-2023)
4.4.3 United States Based Manufacturers Trastuzumab Biosimilars Production (2018-2023)
4.5 China Based Trastuzumab Biosimilars Manufacturers and Market Share
4.5.1 China Based Trastuzumab Biosimilars Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Trastuzumab Biosimilars Production Value (2018-2023)
4.5.3 China Based Manufacturers Trastuzumab Biosimilars Production (2018-2023)
4.6 Rest of World Based Trastuzumab Biosimilars Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Trastuzumab Biosimilars Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Trastuzumab Biosimilars Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Trastuzumab Biosimilars Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Trastuzumab Biosimilars Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Humanized Trastuzumab
5.2.2 Animal-derived Trastuzumab
5.3 Market Segment by Type
5.3.1 World Trastuzumab Biosimilars Production by Type (2018-2029)
5.3.2 World Trastuzumab Biosimilars Production Value by Type (2018-2029)
5.3.3 World Trastuzumab Biosimilars Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Trastuzumab Biosimilars Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Hospital
6.2.2 Clinic
6.3 Market Segment by Application
6.3.1 World Trastuzumab Biosimilars Production by Application (2018-2029)
6.3.2 World Trastuzumab Biosimilars Production Value by Application (2018-2029)
6.3.3 World Trastuzumab Biosimilars Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 Fosun International Limited
7.1.1 Fosun International Limited Details
7.1.2 Fosun International Limited Major Business
7.1.3 Fosun International Limited Trastuzumab Biosimilars Product and Services
7.1.4 Fosun International Limited Trastuzumab Biosimilars Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Fosun International Limited Recent Developments/Updates
7.1.6 Fosun International Limited Competitive Strengths & Weaknesses
7.2 Anhui Anke Bioengineering
7.2.1 Anhui Anke Bioengineering Details
7.2.2 Anhui Anke Bioengineering Major Business
7.2.3 Anhui Anke Bioengineering Trastuzumab Biosimilars Product and Services
7.2.4 Anhui Anke Bioengineering Trastuzumab Biosimilars Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Anhui Anke Bioengineering Recent Developments/Updates
7.2.6 Anhui Anke Bioengineering Competitive Strengths & Weaknesses
7.3 Hisun Biopharmaceuticals
7.3.1 Hisun Biopharmaceuticals Details
7.3.2 Hisun Biopharmaceuticals Major Business
7.3.3 Hisun Biopharmaceuticals Trastuzumab Biosimilars Product and Services
7.3.4 Hisun Biopharmaceuticals Trastuzumab Biosimilars Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Hisun Biopharmaceuticals Recent Developments/Updates
7.3.6 Hisun Biopharmaceuticals Competitive Strengths & Weaknesses
7.4 Chia Tai Tianqing Pharmaceutical Group
7.4.1 Chia Tai Tianqing Pharmaceutical Group Details
7.4.2 Chia Tai Tianqing Pharmaceutical Group Major Business
7.4.3 Chia Tai Tianqing Pharmaceutical Group Trastuzumab Biosimilars Product and Services
7.4.4 Chia Tai Tianqing Pharmaceutical Group Trastuzumab Biosimilars Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Chia Tai Tianqing Pharmaceutical Group Recent Developments/Updates
7.4.6 Chia Tai Tianqing Pharmaceutical Group Competitive Strengths & Weaknesses
7.5 Genentech Inc
7.5.1 Genentech Inc Details
7.5.2 Genentech Inc Major Business
7.5.3 Genentech Inc Trastuzumab Biosimilars Product and Services
7.5.4 Genentech Inc Trastuzumab Biosimilars Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Genentech Inc Recent Developments/Updates
7.5.6 Genentech Inc Competitive Strengths & Weaknesses
7.6 Daiichi Sankyo
7.6.1 Daiichi Sankyo Details
7.6.2 Daiichi Sankyo Major Business
7.6.3 Daiichi Sankyo Trastuzumab Biosimilars Product and Services
7.6.4 Daiichi Sankyo Trastuzumab Biosimilars Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Daiichi Sankyo Recent Developments/Updates
7.6.6 Daiichi Sankyo Competitive Strengths & Weaknesses
7.7 Pfizer
7.7.1 Pfizer Details
7.7.2 Pfizer Major Business
7.7.3 Pfizer Trastuzumab Biosimilars Product and Services
7.7.4 Pfizer Trastuzumab Biosimilars Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Pfizer Recent Developments/Updates
7.7.6 Pfizer Competitive Strengths & Weaknesses
7.8 Celltrion Healthcare
7.8.1 Celltrion Healthcare Details
7.8.2 Celltrion Healthcare Major Business
7.8.3 Celltrion Healthcare Trastuzumab Biosimilars Product and Services
7.8.4 Celltrion Healthcare Trastuzumab Biosimilars Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 Celltrion Healthcare Recent Developments/Updates
7.8.6 Celltrion Healthcare Competitive Strengths & Weaknesses
7.9 Baxter Oncology GmbH
7.9.1 Baxter Oncology GmbH Details
7.9.2 Baxter Oncology GmbH Major Business
7.9.3 Baxter Oncology GmbH Trastuzumab Biosimilars Product and Services
7.9.4 Baxter Oncology GmbH Trastuzumab Biosimilars Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 Baxter Oncology GmbH Recent Developments/Updates
7.9.6 Baxter Oncology GmbH Competitive Strengths & Weaknesses
7.10 Sandoz
7.10.1 Sandoz Details
7.10.2 Sandoz Major Business
7.10.3 Sandoz Trastuzumab Biosimilars Product and Services
7.10.4 Sandoz Trastuzumab Biosimilars Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 Sandoz Recent Developments/Updates
7.10.6 Sandoz Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Trastuzumab Biosimilars Industry Chain
8.2 Trastuzumab Biosimilars Upstream Analysis
8.2.1 Trastuzumab Biosimilars Core Raw Materials
8.2.2 Main Manufacturers of Trastuzumab Biosimilars Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Trastuzumab Biosimilars Production Mode
8.6 Trastuzumab Biosimilars Procurement Model
8.7 Trastuzumab Biosimilars Industry Sales Model and Sales Channels
8.7.1 Trastuzumab Biosimilars Sales Model
8.7.2 Trastuzumab Biosimilars Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Trastuzumab Biosimilars Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Trastuzumab Biosimilars Production Value by Region (2018-2023) & (USD Million)
Table 3. World Trastuzumab Biosimilars Production Value by Region (2024-2029) & (USD Million)
Table 4. World Trastuzumab Biosimilars Production Value Market Share by Region (2018-2023)
Table 5. World Trastuzumab Biosimilars Production Value Market Share by Region (2024-2029)
Table 6. World Trastuzumab Biosimilars Production by Region (2018-2023) & (K Units)
Table 7. World Trastuzumab Biosimilars Production by Region (2024-2029) & (K Units)
Table 8. World Trastuzumab Biosimilars Production Market Share by Region (2018-2023)
Table 9. World Trastuzumab Biosimilars Production Market Share by Region (2024-2029)
Table 10. World Trastuzumab Biosimilars Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Trastuzumab Biosimilars Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Trastuzumab Biosimilars Major Market Trends
Table 13. World Trastuzumab Biosimilars Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Trastuzumab Biosimilars Consumption by Region (2018-2023) & (K Units)
Table 15. World Trastuzumab Biosimilars Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Trastuzumab Biosimilars Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Trastuzumab Biosimilars Producers in 2022
Table 18. World Trastuzumab Biosimilars Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Trastuzumab Biosimilars Producers in 2022
Table 20. World Trastuzumab Biosimilars Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Trastuzumab Biosimilars Company Evaluation Quadrant
Table 22. World Trastuzumab Biosimilars Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Trastuzumab Biosimilars Production Site of Key Manufacturer
Table 24. Trastuzumab Biosimilars Market: Company Product Type Footprint
Table 25. Trastuzumab Biosimilars Market: Company Product Application Footprint
Table 26. Trastuzumab Biosimilars Competitive Factors
Table 27. Trastuzumab Biosimilars New Entrant and Capacity Expansion Plans
Table 28. Trastuzumab Biosimilars Mergers & Acquisitions Activity
Table 29. United States VS China Trastuzumab Biosimilars Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Trastuzumab Biosimilars Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Trastuzumab Biosimilars Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Trastuzumab Biosimilars Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Trastuzumab Biosimilars Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Trastuzumab Biosimilars Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Trastuzumab Biosimilars Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Trastuzumab Biosimilars Production Market Share (2018-2023)
Table 37. China Based Trastuzumab Biosimilars Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Trastuzumab Biosimilars Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Trastuzumab Biosimilars Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Trastuzumab Biosimilars Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Trastuzumab Biosimilars Production Market Share (2018-2023)
Table 42. Rest of World Based Trastuzumab Biosimilars Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Trastuzumab Biosimilars Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Trastuzumab Biosimilars Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Trastuzumab Biosimilars Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Trastuzumab Biosimilars Production Market Share (2018-2023)
Table 47. World Trastuzumab Biosimilars Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Trastuzumab Biosimilars Production by Type (2018-2023) & (K Units)
Table 49. World Trastuzumab Biosimilars Production by Type (2024-2029) & (K Units)
Table 50. World Trastuzumab Biosimilars Production Value by Type (2018-2023) & (USD Million)
Table 51. World Trastuzumab Biosimilars Production Value by Type (2024-2029) & (USD Million)
Table 52. World Trastuzumab Biosimilars Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Trastuzumab Biosimilars Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Trastuzumab Biosimilars Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Trastuzumab Biosimilars Production by Application (2018-2023) & (K Units)
Table 56. World Trastuzumab Biosimilars Production by Application (2024-2029) & (K Units)
Table 57. World Trastuzumab Biosimilars Production Value by Application (2018-2023) & (USD Million)
Table 58. World Trastuzumab Biosimilars Production Value by Application (2024-2029) & (USD Million)
Table 59. World Trastuzumab Biosimilars Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Trastuzumab Biosimilars Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Fosun International Limited Basic Information, Manufacturing Base and Competitors
Table 62. Fosun International Limited Major Business
Table 63. Fosun International Limited Trastuzumab Biosimilars Product and Services
Table 64. Fosun International Limited Trastuzumab Biosimilars Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Fosun International Limited Recent Developments/Updates
Table 66. Fosun International Limited Competitive Strengths & Weaknesses
Table 67. Anhui Anke Bioengineering Basic Information, Manufacturing Base and Competitors
Table 68. Anhui Anke Bioengineering Major Business
Table 69. Anhui Anke Bioengineering Trastuzumab Biosimilars Product and Services
Table 70. Anhui Anke Bioengineering Trastuzumab Biosimilars Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Anhui Anke Bioengineering Recent Developments/Updates
Table 72. Anhui Anke Bioengineering Competitive Strengths & Weaknesses
Table 73. Hisun Biopharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 74. Hisun Biopharmaceuticals Major Business
Table 75. Hisun Biopharmaceuticals Trastuzumab Biosimilars Product and Services
Table 76. Hisun Biopharmaceuticals Trastuzumab Biosimilars Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Hisun Biopharmaceuticals Recent Developments/Updates
Table 78. Hisun Biopharmaceuticals Competitive Strengths & Weaknesses
Table 79. Chia Tai Tianqing Pharmaceutical Group Basic Information, Manufacturing Base and Competitors
Table 80. Chia Tai Tianqing Pharmaceutical Group Major Business
Table 81. Chia Tai Tianqing Pharmaceutical Group Trastuzumab Biosimilars Product and Services
Table 82. Chia Tai Tianqing Pharmaceutical Group Trastuzumab Biosimilars Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Chia Tai Tianqing Pharmaceutical Group Recent Developments/Updates
Table 84. Chia Tai Tianqing Pharmaceutical Group Competitive Strengths & Weaknesses
Table 85. Genentech Inc Basic Information, Manufacturing Base and Competitors
Table 86. Genentech Inc Major Business
Table 87. Genentech Inc Trastuzumab Biosimilars Product and Services
Table 88. Genentech Inc Trastuzumab Biosimilars Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Genentech Inc Recent Developments/Updates
Table 90. Genentech Inc Competitive Strengths & Weaknesses
Table 91. Daiichi Sankyo Basic Information, Manufacturing Base and Competitors
Table 92. Daiichi Sankyo Major Business
Table 93. Daiichi Sankyo Trastuzumab Biosimilars Product and Services
Table 94. Daiichi Sankyo Trastuzumab Biosimilars Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Daiichi Sankyo Recent Developments/Updates
Table 96. Daiichi Sankyo Competitive Strengths & Weaknesses
Table 97. Pfizer Basic Information, Manufacturing Base and Competitors
Table 98. Pfizer Major Business
Table 99. Pfizer Trastuzumab Biosimilars Product and Services
Table 100. Pfizer Trastuzumab Biosimilars Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Pfizer Recent Developments/Updates
Table 102. Pfizer Competitive Strengths & Weaknesses
Table 103. Celltrion Healthcare Basic Information, Manufacturing Base and Competitors
Table 104. Celltrion Healthcare Major Business
Table 105. Celltrion Healthcare Trastuzumab Biosimilars Product and Services
Table 106. Celltrion Healthcare Trastuzumab Biosimilars Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Celltrion Healthcare Recent Developments/Updates
Table 108. Celltrion Healthcare Competitive Strengths & Weaknesses
Table 109. Baxter Oncology GmbH Basic Information, Manufacturing Base and Competitors
Table 110. Baxter Oncology GmbH Major Business
Table 111. Baxter Oncology GmbH Trastuzumab Biosimilars Product and Services
Table 112. Baxter Oncology GmbH Trastuzumab Biosimilars Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. Baxter Oncology GmbH Recent Developments/Updates
Table 114. Sandoz Basic Information, Manufacturing Base and Competitors
Table 115. Sandoz Major Business
Table 116. Sandoz Trastuzumab Biosimilars Product and Services
Table 117. Sandoz Trastuzumab Biosimilars Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 118. Global Key Players of Trastuzumab Biosimilars Upstream (Raw Materials)
Table 119. Trastuzumab Biosimilars Typical Customers
Table 120. Trastuzumab Biosimilars Typical Distributors
LIST OF FIGURE
Figure 1. Trastuzumab Biosimilars Picture
Figure 2. World Trastuzumab Biosimilars Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Trastuzumab Biosimilars Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Trastuzumab Biosimilars Production (2018-2029) & (K Units)
Figure 5. World Trastuzumab Biosimilars Average Price (2018-2029) & (US$/Unit)
Figure 6. World Trastuzumab Biosimilars Production Value Market Share by Region (2018-2029)
Figure 7. World Trastuzumab Biosimilars Production Market Share by Region (2018-2029)
Figure 8. North America Trastuzumab Biosimilars Production (2018-2029) & (K Units)
Figure 9. Europe Trastuzumab Biosimilars Production (2018-2029) & (K Units)
Figure 10. China Trastuzumab Biosimilars Production (2018-2029) & (K Units)
Figure 11. Japan Trastuzumab Biosimilars Production (2018-2029) & (K Units)
Figure 12. Trastuzumab Biosimilars Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Trastuzumab Biosimilars Consumption (2018-2029) & (K Units)
Figure 15. World Trastuzumab Biosimilars Consumption Market Share by Region (2018-2029)
Figure 16. United States Trastuzumab Biosimilars Consumption (2018-2029) & (K Units)
Figure 17. China Trastuzumab Biosimilars Consumption (2018-2029) & (K Units)
Figure 18. Europe Trastuzumab Biosimilars Consumption (2018-2029) & (K Units)
Figure 19. Japan Trastuzumab Biosimilars Consumption (2018-2029) & (K Units)
Figure 20. South Korea Trastuzumab Biosimilars Consumption (2018-2029) & (K Units)
Figure 21. ASEAN Trastuzumab Biosimilars Consumption (2018-2029) & (K Units)
Figure 22. India Trastuzumab Biosimilars Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of Trastuzumab Biosimilars by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Trastuzumab Biosimilars Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Trastuzumab Biosimilars Markets in 2022
Figure 26. United States VS China: Trastuzumab Biosimilars Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Trastuzumab Biosimilars Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Trastuzumab Biosimilars Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Trastuzumab Biosimilars Production Market Share 2022
Figure 30. China Based Manufacturers Trastuzumab Biosimilars Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Trastuzumab Biosimilars Production Market Share 2022
Figure 32. World Trastuzumab Biosimilars Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Trastuzumab Biosimilars Production Value Market Share by Type in 2022
Figure 34. Humanized Trastuzumab
Figure 35. Animal-derived Trastuzumab
Figure 36. World Trastuzumab Biosimilars Production Market Share by Type (2018-2029)
Figure 37. World Trastuzumab Biosimilars Production Value Market Share by Type (2018-2029)
Figure 38. World Trastuzumab Biosimilars Average Price by Type (2018-2029) & (US$/Unit)
Figure 39. World Trastuzumab Biosimilars Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 40. World Trastuzumab Biosimilars Production Value Market Share by Application in 2022
Figure 41. Hospital
Figure 42. Clinic
Figure 43. World Trastuzumab Biosimilars Production Market Share by Application (2018-2029)
Figure 44. World Trastuzumab Biosimilars Production Value Market Share by Application (2018-2029)
Figure 45. World Trastuzumab Biosimilars Average Price by Application (2018-2029) & (US$/Unit)
Figure 46. Trastuzumab Biosimilars Industry Chain
Figure 47. Trastuzumab Biosimilars Procurement Model
Figure 48. Trastuzumab Biosimilars Sales Model
Figure 49. Trastuzumab Biosimilars Sales Channels, Direct Sales, and Distribution
Figure 50. Methodology
Figure 51. Research Process and Data Source
Table 1. World Trastuzumab Biosimilars Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Trastuzumab Biosimilars Production Value by Region (2018-2023) & (USD Million)
Table 3. World Trastuzumab Biosimilars Production Value by Region (2024-2029) & (USD Million)
Table 4. World Trastuzumab Biosimilars Production Value Market Share by Region (2018-2023)
Table 5. World Trastuzumab Biosimilars Production Value Market Share by Region (2024-2029)
Table 6. World Trastuzumab Biosimilars Production by Region (2018-2023) & (K Units)
Table 7. World Trastuzumab Biosimilars Production by Region (2024-2029) & (K Units)
Table 8. World Trastuzumab Biosimilars Production Market Share by Region (2018-2023)
Table 9. World Trastuzumab Biosimilars Production Market Share by Region (2024-2029)
Table 10. World Trastuzumab Biosimilars Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Trastuzumab Biosimilars Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Trastuzumab Biosimilars Major Market Trends
Table 13. World Trastuzumab Biosimilars Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Trastuzumab Biosimilars Consumption by Region (2018-2023) & (K Units)
Table 15. World Trastuzumab Biosimilars Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Trastuzumab Biosimilars Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Trastuzumab Biosimilars Producers in 2022
Table 18. World Trastuzumab Biosimilars Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Trastuzumab Biosimilars Producers in 2022
Table 20. World Trastuzumab Biosimilars Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Trastuzumab Biosimilars Company Evaluation Quadrant
Table 22. World Trastuzumab Biosimilars Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Trastuzumab Biosimilars Production Site of Key Manufacturer
Table 24. Trastuzumab Biosimilars Market: Company Product Type Footprint
Table 25. Trastuzumab Biosimilars Market: Company Product Application Footprint
Table 26. Trastuzumab Biosimilars Competitive Factors
Table 27. Trastuzumab Biosimilars New Entrant and Capacity Expansion Plans
Table 28. Trastuzumab Biosimilars Mergers & Acquisitions Activity
Table 29. United States VS China Trastuzumab Biosimilars Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Trastuzumab Biosimilars Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Trastuzumab Biosimilars Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Trastuzumab Biosimilars Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Trastuzumab Biosimilars Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Trastuzumab Biosimilars Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Trastuzumab Biosimilars Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Trastuzumab Biosimilars Production Market Share (2018-2023)
Table 37. China Based Trastuzumab Biosimilars Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Trastuzumab Biosimilars Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Trastuzumab Biosimilars Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Trastuzumab Biosimilars Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Trastuzumab Biosimilars Production Market Share (2018-2023)
Table 42. Rest of World Based Trastuzumab Biosimilars Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Trastuzumab Biosimilars Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Trastuzumab Biosimilars Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Trastuzumab Biosimilars Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Trastuzumab Biosimilars Production Market Share (2018-2023)
Table 47. World Trastuzumab Biosimilars Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Trastuzumab Biosimilars Production by Type (2018-2023) & (K Units)
Table 49. World Trastuzumab Biosimilars Production by Type (2024-2029) & (K Units)
Table 50. World Trastuzumab Biosimilars Production Value by Type (2018-2023) & (USD Million)
Table 51. World Trastuzumab Biosimilars Production Value by Type (2024-2029) & (USD Million)
Table 52. World Trastuzumab Biosimilars Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Trastuzumab Biosimilars Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Trastuzumab Biosimilars Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Trastuzumab Biosimilars Production by Application (2018-2023) & (K Units)
Table 56. World Trastuzumab Biosimilars Production by Application (2024-2029) & (K Units)
Table 57. World Trastuzumab Biosimilars Production Value by Application (2018-2023) & (USD Million)
Table 58. World Trastuzumab Biosimilars Production Value by Application (2024-2029) & (USD Million)
Table 59. World Trastuzumab Biosimilars Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Trastuzumab Biosimilars Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Fosun International Limited Basic Information, Manufacturing Base and Competitors
Table 62. Fosun International Limited Major Business
Table 63. Fosun International Limited Trastuzumab Biosimilars Product and Services
Table 64. Fosun International Limited Trastuzumab Biosimilars Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Fosun International Limited Recent Developments/Updates
Table 66. Fosun International Limited Competitive Strengths & Weaknesses
Table 67. Anhui Anke Bioengineering Basic Information, Manufacturing Base and Competitors
Table 68. Anhui Anke Bioengineering Major Business
Table 69. Anhui Anke Bioengineering Trastuzumab Biosimilars Product and Services
Table 70. Anhui Anke Bioengineering Trastuzumab Biosimilars Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Anhui Anke Bioengineering Recent Developments/Updates
Table 72. Anhui Anke Bioengineering Competitive Strengths & Weaknesses
Table 73. Hisun Biopharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 74. Hisun Biopharmaceuticals Major Business
Table 75. Hisun Biopharmaceuticals Trastuzumab Biosimilars Product and Services
Table 76. Hisun Biopharmaceuticals Trastuzumab Biosimilars Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Hisun Biopharmaceuticals Recent Developments/Updates
Table 78. Hisun Biopharmaceuticals Competitive Strengths & Weaknesses
Table 79. Chia Tai Tianqing Pharmaceutical Group Basic Information, Manufacturing Base and Competitors
Table 80. Chia Tai Tianqing Pharmaceutical Group Major Business
Table 81. Chia Tai Tianqing Pharmaceutical Group Trastuzumab Biosimilars Product and Services
Table 82. Chia Tai Tianqing Pharmaceutical Group Trastuzumab Biosimilars Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Chia Tai Tianqing Pharmaceutical Group Recent Developments/Updates
Table 84. Chia Tai Tianqing Pharmaceutical Group Competitive Strengths & Weaknesses
Table 85. Genentech Inc Basic Information, Manufacturing Base and Competitors
Table 86. Genentech Inc Major Business
Table 87. Genentech Inc Trastuzumab Biosimilars Product and Services
Table 88. Genentech Inc Trastuzumab Biosimilars Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Genentech Inc Recent Developments/Updates
Table 90. Genentech Inc Competitive Strengths & Weaknesses
Table 91. Daiichi Sankyo Basic Information, Manufacturing Base and Competitors
Table 92. Daiichi Sankyo Major Business
Table 93. Daiichi Sankyo Trastuzumab Biosimilars Product and Services
Table 94. Daiichi Sankyo Trastuzumab Biosimilars Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Daiichi Sankyo Recent Developments/Updates
Table 96. Daiichi Sankyo Competitive Strengths & Weaknesses
Table 97. Pfizer Basic Information, Manufacturing Base and Competitors
Table 98. Pfizer Major Business
Table 99. Pfizer Trastuzumab Biosimilars Product and Services
Table 100. Pfizer Trastuzumab Biosimilars Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Pfizer Recent Developments/Updates
Table 102. Pfizer Competitive Strengths & Weaknesses
Table 103. Celltrion Healthcare Basic Information, Manufacturing Base and Competitors
Table 104. Celltrion Healthcare Major Business
Table 105. Celltrion Healthcare Trastuzumab Biosimilars Product and Services
Table 106. Celltrion Healthcare Trastuzumab Biosimilars Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Celltrion Healthcare Recent Developments/Updates
Table 108. Celltrion Healthcare Competitive Strengths & Weaknesses
Table 109. Baxter Oncology GmbH Basic Information, Manufacturing Base and Competitors
Table 110. Baxter Oncology GmbH Major Business
Table 111. Baxter Oncology GmbH Trastuzumab Biosimilars Product and Services
Table 112. Baxter Oncology GmbH Trastuzumab Biosimilars Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. Baxter Oncology GmbH Recent Developments/Updates
Table 114. Sandoz Basic Information, Manufacturing Base and Competitors
Table 115. Sandoz Major Business
Table 116. Sandoz Trastuzumab Biosimilars Product and Services
Table 117. Sandoz Trastuzumab Biosimilars Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 118. Global Key Players of Trastuzumab Biosimilars Upstream (Raw Materials)
Table 119. Trastuzumab Biosimilars Typical Customers
Table 120. Trastuzumab Biosimilars Typical Distributors
LIST OF FIGURE
Figure 1. Trastuzumab Biosimilars Picture
Figure 2. World Trastuzumab Biosimilars Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Trastuzumab Biosimilars Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Trastuzumab Biosimilars Production (2018-2029) & (K Units)
Figure 5. World Trastuzumab Biosimilars Average Price (2018-2029) & (US$/Unit)
Figure 6. World Trastuzumab Biosimilars Production Value Market Share by Region (2018-2029)
Figure 7. World Trastuzumab Biosimilars Production Market Share by Region (2018-2029)
Figure 8. North America Trastuzumab Biosimilars Production (2018-2029) & (K Units)
Figure 9. Europe Trastuzumab Biosimilars Production (2018-2029) & (K Units)
Figure 10. China Trastuzumab Biosimilars Production (2018-2029) & (K Units)
Figure 11. Japan Trastuzumab Biosimilars Production (2018-2029) & (K Units)
Figure 12. Trastuzumab Biosimilars Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Trastuzumab Biosimilars Consumption (2018-2029) & (K Units)
Figure 15. World Trastuzumab Biosimilars Consumption Market Share by Region (2018-2029)
Figure 16. United States Trastuzumab Biosimilars Consumption (2018-2029) & (K Units)
Figure 17. China Trastuzumab Biosimilars Consumption (2018-2029) & (K Units)
Figure 18. Europe Trastuzumab Biosimilars Consumption (2018-2029) & (K Units)
Figure 19. Japan Trastuzumab Biosimilars Consumption (2018-2029) & (K Units)
Figure 20. South Korea Trastuzumab Biosimilars Consumption (2018-2029) & (K Units)
Figure 21. ASEAN Trastuzumab Biosimilars Consumption (2018-2029) & (K Units)
Figure 22. India Trastuzumab Biosimilars Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of Trastuzumab Biosimilars by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Trastuzumab Biosimilars Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Trastuzumab Biosimilars Markets in 2022
Figure 26. United States VS China: Trastuzumab Biosimilars Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Trastuzumab Biosimilars Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Trastuzumab Biosimilars Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Trastuzumab Biosimilars Production Market Share 2022
Figure 30. China Based Manufacturers Trastuzumab Biosimilars Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Trastuzumab Biosimilars Production Market Share 2022
Figure 32. World Trastuzumab Biosimilars Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Trastuzumab Biosimilars Production Value Market Share by Type in 2022
Figure 34. Humanized Trastuzumab
Figure 35. Animal-derived Trastuzumab
Figure 36. World Trastuzumab Biosimilars Production Market Share by Type (2018-2029)
Figure 37. World Trastuzumab Biosimilars Production Value Market Share by Type (2018-2029)
Figure 38. World Trastuzumab Biosimilars Average Price by Type (2018-2029) & (US$/Unit)
Figure 39. World Trastuzumab Biosimilars Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 40. World Trastuzumab Biosimilars Production Value Market Share by Application in 2022
Figure 41. Hospital
Figure 42. Clinic
Figure 43. World Trastuzumab Biosimilars Production Market Share by Application (2018-2029)
Figure 44. World Trastuzumab Biosimilars Production Value Market Share by Application (2018-2029)
Figure 45. World Trastuzumab Biosimilars Average Price by Application (2018-2029) & (US$/Unit)
Figure 46. Trastuzumab Biosimilars Industry Chain
Figure 47. Trastuzumab Biosimilars Procurement Model
Figure 48. Trastuzumab Biosimilars Sales Model
Figure 49. Trastuzumab Biosimilars Sales Channels, Direct Sales, and Distribution
Figure 50. Methodology
Figure 51. Research Process and Data Source
